HOOKIPA Pharma Inc.
NASDAQ:HOOK
3.81 (USD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 117.096 | 113.444 | 66.912 | 143.177 | 113.151 | 48.58 | 61.362 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 117.096 | 113.444 | 66.912 | 143.177 | 113.151 | 48.58 | 61.362 |
| Net Receivables
| 19.271 | 22.012 | 21.166 | 20.657 | 9.727 | 4.919 | 6.52 |
| Inventory
| 0 | -0.419 | -15.262 | -15.549 | -8.19 | 0 | 0 |
| Other Current Assets
| 10.749 | 12.159 | 29.319 | 23.219 | 13.329 | 8.812 | 2.076 |
| Total Current Assets
| 147.116 | 147.196 | 102.135 | 171.504 | 128.017 | 62.311 | 69.958 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 13.215 | 21.976 | 22.115 | 13.969 | 14.603 | 4.337 | 3.575 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0.425 | 0.419 | 0.425 | 0.434 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.581 | 0.863 | 1.37 | 1.91 | 1.125 | 1.603 | 0.199 |
| Total Non-Current Assets
| 14.221 | 23.258 | 23.91 | 16.313 | 15.728 | 5.94 | 3.774 |
| Total Assets
| 161.337 | 170.454 | 126.045 | 187.817 | 143.745 | 68.251 | 73.732 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 12.498 | 5.488 | 8.762 | 8.009 | 0.944 | 3.656 | 1.477 |
| Short Term Debt
| 2.758 | 3.282 | 4.495 | 2.153 | 1.814 | 0 | 0 |
| Tax Payables
| 0.367 | 0.23 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 14.683 | 15.984 | 6.231 | 4.628 | 3.591 | 7.452 | 0.725 |
| Other Current Liabilities
| 12.049 | 10.878 | 8.166 | 6.353 | 8.406 | 3.587 | 1.833 |
| Total Current Liabilities
| 41.988 | 35.632 | 27.654 | 21.143 | 14.755 | 14.695 | 4.035 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 3.801 | 3.221 | 6.13 | 8.356 | 8.785 | 4.392 | 3.738 |
| Deferred Revenue Non-Current
| 19.674 | 25.664 | 0.021 | 0.784 | 0.072 | 1.663 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 6.017 | 3.42 | 2.648 | 1.411 | 2.234 | 3.102 | 108.615 |
| Total Non-Current Liabilities
| 29.492 | 32.305 | 8.799 | 10.551 | 11.091 | 9.157 | 112.353 |
| Total Liabilities
| 71.48 | 67.937 | 36.453 | 31.694 | 25.846 | 23.852 | 116.388 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 143.745 | 104.774 | 104.774 |
| Common Stock
| 0.01 | 0.005 | 0.003 | 0.003 | 0.003 | 0.002 | 0 |
| Retained Earnings
| -369.261 | -287.681 | -222.766 | -147.101 | -103.019 | -59.982 | -43.745 |
| Accumulated Other Comprehensive Income/Loss
| -7.933 | -7.156 | -4.78 | -6.067 | -4.653 | -3.72 | -1.362 |
| Other Total Stockholders Equity
| 467.041 | 397.349 | 317.135 | 309.288 | 81.823 | 3.325 | -102.323 |
| Total Shareholders Equity
| 89.857 | 102.517 | 89.592 | 156.123 | 117.899 | 44.399 | -42.656 |
| Total Equity
| 89.857 | 102.517 | 89.592 | 156.123 | 117.899 | 44.399 | -42.656 |
| Total Liabilities & Shareholders Equity
| 161.337 | 170.454 | 126.045 | 187.817 | 143.745 | 68.251 | 73.732 |